share_log

Cardio Diagnostics | CORRESP: CORRESP

SEC announcement ·  Jan 30 12:15
Summary by Moomoo AI
Cardio Diagnostics Holdings, Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a correspondence dated January 30, 2024. The company has sought for the Registration Statement, with File No. 333-276725, to be declared effective on February 1, 2024, at 11:00 a.m. Eastern Time or as soon thereafter as practicable. This request was made under Rule 461 of the Securities Act of 1933, as amended. Cardio Diagnostics Holdings has indicated that once the Registration Statement is declared effective, the SEC should orally confirm the event with the company's counsel, Shartsis Friese LLP, specifically Rupert Russell. Any questions or comments from the SEC regarding this acceleration request are to be directed to Mr. Russell.
Cardio Diagnostics Holdings, Inc. has formally requested the U.S. Securities and Exchange Commission (SEC) to accelerate the effective date of its Registration Statement on Form S-3, as per a correspondence dated January 30, 2024. The company has sought for the Registration Statement, with File No. 333-276725, to be declared effective on February 1, 2024, at 11:00 a.m. Eastern Time or as soon thereafter as practicable. This request was made under Rule 461 of the Securities Act of 1933, as amended. Cardio Diagnostics Holdings has indicated that once the Registration Statement is declared effective, the SEC should orally confirm the event with the company's counsel, Shartsis Friese LLP, specifically Rupert Russell. Any questions or comments from the SEC regarding this acceleration request are to be directed to Mr. Russell.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more